JSM Activity #158

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2002 Program page


Activity ID:  158
Title
Statistical Issues in Cost-effectiveness Analysis
Date / Time / Room Sponsor Type
08/13/2002
8:30 AM - 10:20 AM
Room: H-Regent Parlor 		Biometrics Section*, Biopharmaceutical Section*, ENAR, Section on Health Policy Statistics* Invited
Organizer: Eugene Laska, Nathan Kline Institue, NYU School of Medicine
Chair: Alan J. Moskowitz, Columbia University
Discussant: 9:50 AM - John Mullahy, University of Wisconsin    
Floor Discussion 10:05 AM
Description

An important element of the analysis of biological and service interventions is their cost-effectiveness. The deterministic underpinnings of the field are relatively well settled but statistical theory for the analysis of CE data is still in its infancy. Recent developments have proceeded along both frequentist and Bayesian lines. The speakers in this session will present the latest approaches from both of these perspectives.
  300023  By:  Anthony  O'Hagan 8:35 AM 08/13/2002
Bayesian Methods for Cost-Effectiveness Analysis in Health Economics

  300024  By:  Eugene  Laska 9:00 AM 08/13/2002
Determination of the Statistical Frontier in a Cost-effectiveness Analysis

  300025  By:  Joseph C. Gardiner 9:25 AM 08/13/2002
Longitudinal Models for the Analysis of Health Care Costs and Outcomes: Application to Cost-Effectiveness Analysis

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002